Syndax Pharmaceuticals, Inc.SNDXNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
7.67%
↓ 93% below average
Average (39q)
116.93%
Historical baseline
Range
High:3165.17%
Low:-100.00%
Volatility
2792.5%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 7.67% |
| Q2 2025 | 91.47% |
| Q1 2025 | 149.44% |
| Q4 2024 | -38.56% |
| Q3 2024 | 257.14% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | -100.00% |
| Q4 2021 | 921.86% |
| Q3 2021 | 3165.17% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | -0.26% |
| Q4 2019 | 0.26% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | -0.26% |
| Q4 2018 | 0.26% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -68.23% |
| Q4 2017 | 291.15% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |